Bluejay Diagnostics, Inc. (BJDX) vs Sunshine Biopharma, Inc. (SBFM)
A side-by-side comparison of Bluejay Diagnostics, Inc. and Sunshine Biopharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BJDX
Bluejay Diagnostics, Inc.
$0.82HealthcareDelayed quote: Oct 6, 2026, 2:17 PM EDT
SBFM
Sunshine Biopharma, Inc.
$0.36HealthcareDelayed quote: Oct 6, 2026, 2:19 PM EDT
Total return — BJDX vs SBFM
growth of $100 · dividends reinvested · last 5yBJDX -100.0% (-90.6%/yr)SBFM -100.0% (-86.1%/yr)SBFM compounded faster over this window
Log scale — wide-divergence pair
BJDX SBFM
BJDX vs SBFM: by the numbers
- •SBFM is the larger company ($858334 vs $849293 market cap).
- •Both run net losses; BJDX's is the smaller (0.00% vs -16.50% net margin).
Metrics side by side
Valuation
| Metric | BJDX | SBFM |
|---|---|---|
| P/S ratio | N/A | 0.02 |
| P/B ratio | 0.09 | 0.03 |
Profitability
| Metric | BJDX | SBFM |
|---|---|---|
| Gross margin | 0.00% | 29.80% |
| Operating margin | 0.00% | -14.71% |
| Net margin | 0.00% | -16.50% |
| ROE | -77.23% | -21.18% |
| ROIC | -77.55% | -18.56% |
Growth (annualized)
| Metric | BJDX | SBFM |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 203.18% |
Go deeper
Dig into the metrics
Bluejay Diagnostics ROESunshine Biopharma ROEBluejay Diagnostics operating marginSunshine Biopharma operating marginBluejay Diagnostics revenue growthSunshine Biopharma revenue growthBluejay Diagnostics free cash flowSunshine Biopharma free cash flow
Bluejay Diagnostics & Sunshine Biopharma appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.